Elsevier, the information analytics company specialising in science and health, and HIMSS, the Healthcare Information and Management System Society, jointly announced that nominations are open for the second HIMSS-Elsevier Digital Healthcare Award in Europe.

Novartis has announced an additional strategic alliance with Science 37, a leader in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the next three years. The studies will blend virtual and traditional models, with increasing degrees of decentralization towards a mostly "site-less" model.

Allscripts Healthcare Solutions (NASDAQ:MDRX) unveiled its new electronic health record (EHR), AvenelTM, at the annual HIMSS conference today. Mobile-first and cloud-based, Avenel creates a community-wide shared patient record, uses machine learning to reduce time for clinical documentation and is designed to work like an app instead of traditional software.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of IntelliSpace Cardiovascular 3.1, its next-generation cardiovascular image and information management system. Designed to help streamline workflow and improve operational performance throughout the cardiovascular service line, the latest version features enhanced security and enterprise protocols, seamless access to Philips' QLAB and TOMTEC software tools, and the addition of browser-based reporting of stress echocardiogram (stress echo) tests.

Novartis has entered into a collaboration with Pear Therapeutics to develop novel prescription digital therapeutics, software applications designed to effectively treat disease and improve clinical outcomes for patients. The collaboration brings together Novartis expertise in biomedical research and clinical development with Pear's leading experience in digital therapeutics design and implementation.

Ahead of the 2018 Annual Healthcare Information and Management Systems Society (HIMSS) Conference, Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced the Philips eICU program has helped Avera Health, a South Dakota-based integrated health system, enhance care quality and efficiency by partnering to deliver significant clinical and financial outcomes through the ICU division of their telemedicine program, Avera eCARE®.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that Advanced ICU Care, the largest provider of tele-ICU care in the U.S., has extended its collaboration with Philips by signing a new 12-year agreement. A Philips tele-ICU customer since 2006, Advanced ICU Care will leverage Philips' tele-ICU technology to help power nine virtual care hubs, monitoring nearly 1,000 ICU beds across the U.S.